振东制药：累计回购公司股份12916700股

Group 1 - The company, Zhendong Pharmaceutical, announced that as of July 31, 2025, it has repurchased a total of 12,916,700 shares through a dedicated securities account via centralized bidding, which represents 1.28% of the company's current total share capital [2]